Trends
- John W. A. Eikelboom, MD, PhD, McMaster University, Hamilton, Canada
>International trends in clinical intervention research - Prof. Huib Pols, MD, Erasmus MC, Rotterdam, The Netherlands
>Position of clinical intervention research in the Netherlands and recent trends
- Prof. Jan P. Vandenbroucke, MD, University Medical Center, Leiden, TheNetherlands
>Sponsor- versus investigator-initiated clinical intervention research - Prof. Harry R. Büller, MD, AMC, Amsterdam, The Netherlands
>How to find a balance between sponsors and investigators in clinical intervention research? <i> - Pauline Williams, MD, PhD, Head of the Academic Drug Performance Unit, GlaxoSmithKline
>What do pharmaceutical companies need from independent investigators?
- Prof. George E. Griffin, MD, St George's University of London, United Kingdom
>Good clinical practice guidelines and the European directive: how can investigator-initiated research survive? - Prof. Adam F. Cohen, Center for Human Drug Research, Leiden, The Netherlands
>Requirements for early phase drug research - Kirsten Steinhausen, PhD, German Research Association/German Ministry of Education and Research, Berlin
>Infrastructure requirements of investigator-initiated trials - Prof. Jos W.M. van der Meer, vice-president of the Academy
>Closing Remarks